CCI
38
2
DE
43
-2
JBHT
62
-3
JNJ
51
-3
M
49
-4
MU
76
-3
DRI
60
-3
ECL
59
-3
EQT
56
6
VMC
57
4
ADT
46
-4
AA
80
-3
SWKS
46
-2
MAC
70
2
CPB
35
-4
NWL
54
-4
GRMN
39
-6
FITB
73
-5
KSS
56
-2
GPC
51
-2
CCI
38
2
DE
43
-2
JBHT
62
-3
JNJ
51
-3
M
49
-4
MU
76
-3
DRI
60
-3
ECL
59
-3
EQT
56
6
VMC
57
4
ADT
46
-4
AA
80
-3
SWKS
46
-2
MAC
70
2
CPB
35
-4
NWL
54
-4
GRMN
39
-6
FITB
73
-5
KSS
56
-2
GPC
51
-2
Financhill
Back

Greenlight Capital Re Ltd. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
62

GLRE
Greenlight Capital Re Ltd.

Last Price:
$14.73
Seasonality Move:
-0.18%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.83
Seasonality Move:
0.59%
Buy
62
Greenlight Capital Re Ltd. (GLRE) is a Buy

Is Greenlight Capital Re Ltd. a Buy, Sell or Hold?

  • The current Greenlight Capital Re Ltd. [GLRE] share price is $14.72. The Score for GLRE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLRE Stock Price Chart

What is Greenlight Capital Re Ltd.'s stock price today?

  • The Greenlight Capital Re Ltd. share price today is $14.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLRE is experiencing slight buying pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.43 Buy
Relative Strength Index (14 RSI): 74.1 Buy
Chaikin Money Flow: 36773 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.12 - 14.36) Buy
Bollinger Bands (100): (12.33 - 13.57) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.79 Buy
Relative Strength Index (14 RSI): 61.76 Buy
Chaikin Money Flow: 156273 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.4 - 40.3) Buy
Bollinger Bands (100): (17.9 - 35) Buy

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.46 Buy
20-day SMA: 13.96 Buy
50-day SMA: 13.11 Buy
200-day SMA: 13.29 Buy
8-day EMA: 14.42 Buy
20-day EMA: 14.01 Buy
50-day EMA: 13.45 Buy
200-day EMA: 13.25 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.78 Buy
20-day SMA: 38.2 Buy
50-day SMA: 33.84 Buy
200-day SMA: 18.39 Buy
8-day EMA: 28.27 Buy
20-day EMA: 15.3 Buy
50-day EMA: 7 Buy
200-day EMA: 1.88 Buy

Greenlight Capital Re Ltd. Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Greenlight Capital Re Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):